

Published 7/31/2023
The price of the vaccine provided by Mehiläinen during the influenza season 2026–2027 will be announced in autumn 2026.
Possible time-bound promotional prices may differ from these.
| Service | Price | Info |
|---|---|---|
| Hepatitis A (adult) | 121,50 € No Kela reimbursement Price 121,50 € No Kela reimbursement | |
| Hepatitis A (under 16 years old) Information about the traveler's vaccinations. | 95,70 € No Kela reimbursement Price 95,70 € No Kela reimbursement | Information about the traveler's vaccinations. |
| Hepatitis A+B vaccine (adult) | Mobile Benefit 122,00 € 134,90 € No Kela reimbursement Mobile Benefit 122,00 € Price 134,90 € No Kela reimbursement | |
| Hepatitis A+B vaccine (under 16 years old) | Mobile Benefit 96,00 € 112,30 € No Kela reimbursement Mobile Benefit 96,00 € Price 112,30 € No Kela reimbursement | |
| Tetanus and diphtheria vaccine Information about the tetanus-diphtheria vaccine. Book an appointment for vaccination | 65,80 € No Kela reimbursement Price 65,80 € No Kela reimbursement | Information about the tetanus-diphtheria vaccine. Book an appointment for vaccination |
| Tetanus-diphtheria-pertussis (dtap) vaccine Information about the tetanus-diphtheria-pertussis vaccine. | 81,60 € No Kela reimbursement Price 81,60 € No Kela reimbursement | Information about the tetanus-diphtheria-pertussis vaccine. |
| COVID-19 vaccine | 144,50 € No Kela reimbursement Price 144,50 € No Kela reimbursement | |
| Pneumococcal vaccine The price of the pneumococcal vaccination, depending on the vaccine, is 144.30–169.50 €. More information about the pneumococcal vaccine. Book an appointment for pneumococcal vaccination | from 144,30 € No Kela reimbursement Price from 144,30 € No Kela reimbursement | The price of the pneumococcal vaccination, depending on the vaccine, is 144.30–169.50 €. More information about the pneumococcal vaccine. Book an appointment for pneumococcal vaccination |
| Tick-borne encephalitis vaccine (adults) Price per vaccination. More information about the tick-borne encephalitis vaccine. Book an appointment for tick-borne encephalitis vaccination | Mobile Benefit 66,00 € 80,50 € No Kela reimbursement Mobile Benefit 66,00 € Price 80,50 € No Kela reimbursement | Price per vaccination. More information about the tick-borne encephalitis vaccine. Book an appointment for tick-borne encephalitis vaccination |
| Tick-borne encephalitis vaccine (children) Price per vaccination. More information about the tick-borne encephalitis vaccine. Book an appointment for tick-borne encephalitis vaccination | Mobile Benefit 66,00 € 77,60 € No Kela reimbursement Mobile Benefit 66,00 € Price 77,60 € No Kela reimbursement | Price per vaccination. More information about the tick-borne encephalitis vaccine. Book an appointment for tick-borne encephalitis vaccination |
Over the course of an ordinary influenza epidemic, about one in ten adults will get influenza. Getting vaccinated is the best way to protect yourself against influenza. Most people who get vaccinated will not get influenza. If a person who has received the influenza vaccine gets influenza, the illness is usually milder and does not last as long. In addition to preventing influenza complications, the influenza vaccine also prevents ear infections: the rate of ear infections over the influenza season has been up to a third lower in children who have been vaccinated against influenza. By getting vaccinated, you can also help prevent the spread of influenza and protect both your loved ones and those in high-risk groups.
Learn more:
What are the influenza high-risk groups?
We recommend getting vaccinated in the autumn, before the start of the influenza season. It takes about two weeks for antibodies to develop, and the protection against the illness will not be complete during that time. You can also get vaccinated after the epidemic has already begun, but there is a risk of infection before the antibodies have fully developed. The vaccine will not be harmful in such a situation and will not lead to an illness that is more severe than usual. However, please note that you may not get vaccinated while you have a fever or have an infection that is causing a fever.
You can get a high-dose influenza vaccine even if you have never had an influenza vaccine before. The high-dose influenza vaccine is generally suitable for anyone who is able to have the standard influenza vaccine.
The influenza vaccine given as nasal spray is intended for children aged 2–17. The influenza vaccine given as nasal spray cannot be administered for children under two years of age, but they are offered an injected vaccine instead.
For the 2026 influenza season, Mehiläinen uses vaccines that are in line with WHO recommendations.
In addition, a high-dose influenza vaccine is available for people aged over 60. The high-dose vaccine contains a larger amount of active ingredient than the standard vaccine used in the national vaccination programme.
In addition to the injectable vaccines, a nasal spray influenza vaccine is available for children aged 2–17. The virus strains used in all the vaccines are in line with WHO recommendations.
You must have a new influenza vaccine every year as the influenza viruses in circulation change from year to year.
Do you know how many of your company’s employees have influenza during the year? Do you know how much influenza infections costs your company?
In people of working age, the influenza vaccine prevents 7–8 cases out of 10. Check the calculator to see what vaccination would mean for your organisation.
Corporate decision makers can contact us and agree on vaccinations with their organisation’s occupational health nurse.
COVID-19 vaccination
The updated vaccines offer better protection against new virus variants.
HPV vaccine
The HPV vaccine provides protection against the most common high-risk HPV viruses.
Influenza vaccine high-dose
A more effective flu vaccine designed for those over 60.
Influenza vaccine nasal spray
A painless flu vaccination designed for children over 2 years old.
Tick-borne encephalitis vaccine
Three doses provide basic protection. Prevents about 90% of tick-borne encephalitis infections.
The influenza vaccine used at Mehiläinen protects against both influenza A virus strains and both influenza B strains.
We recommend getting vaccinated in the autumn, before the start of the influenza season. It takes about two weeks for the immunity to develop, during which the protection against the illness will not be complete. You can also get vaccinated after the epidemic has already begun, but there is a risk of contracting influenza before the antibodies have fully developed.
You must have a new seasonal influenza vaccine every year as the influenza viruses in circulation mutate and change from year to year.
High-risk groups for influenza and everyone whose immediate circle involves a person at a risk of contracting severe influenza are recommended to get vaccinated against influenza.
High-risk groups for influenza:
The vaccine cannot be administered if you have a high fever or an infection that is causing a fever and it must be postponed until you feel better.
The presence of the following diseases should be considered when getting vaccinated:
Nasally administered vaccines cannot be given to:
The vaccine cannot be administered if you have had a severe, immediate allergic reaction, i.e. anaphylaxis, to an influenza vaccine.
An influenza vaccine can be administered as an injection at any stage of pregnancy. Vaccines administered nasally are not recommended at all during pregnancy.
It is possible to contract influenza even if you have been vaccinated. The influenza vaccine does not provide complete protection against influenza or prevent you from spreading it while you are asymptomatic, but it is the best form of protection against the disease. If you contract influenza when you are vaccinated, you will most likely experience only mild symptoms and recover more quickly than without the vaccine. You should also get vaccinated if you want protection against the sequelae of influenza, such as otitis or bronchitis in children and pneumonia in people of all ages.
The adverse effects of influenza vaccines are rare and occur in only a small proportion of vaccinated individuals:
Serious adverse effects, such as severe allergic reactions (anaphylaxis) occur very rarely.
You may experience mild symptoms of a cold after getting vaccinated. These are normal and will subside spontaneously in a short time. Please note that these short term reactions to the vaccine are not a reason for getting tested for COVID-19. If the symptoms last longer than 24 hours after the vaccination and/or if you clearly feel that you are ill or have a high fever or symptoms of a respiratory tract infection, you must contact a health care service provider in order to assess the possibility of a COVID-19 infection.
Healthy days are important to an athlete, and infection prevention plays an important role in maintaining health and good performance. This is why influenza vaccination is a strongly recommended method of protection for athletes and others alike.
It is also beneficial for the athlete if their immediate family and, possibly the entire sports team, have been vaccinated.
Athletes spend a lot of time in groups: either in teams or in training groups. They are, therefore, quite often in close contact with other people, which increases the risk of a respiratory tract infection.
Athletes may travel quite a lot, for example, for competitions or training, which also increases the risk of getting ill.
Prevention of infections is beneficial, and the side effects of vaccines are usually smaller than the overall benefit of getting vaccinated.
Influenza vaccination does not cause the vaccine recipient the actual influenza, but vaccination can cause some side effects. If the vaccine causes side effects, they are generally mild, such as pain at the injection location, fatigue, headache and muscle pain. Sometimes people may also experience mild and brief fever. The symptoms usually last up to a few days.
Protection against influenza does not occur immediately after vaccination, but takes about two weeks to develop from the time of vaccination. The recommended time for vaccination is before the start of the influenza season, November-December.
After getting the vaccine, it’s a good idea to have enough space in the training calendar – it’s not a good idea to schedule very heavy workouts or important competitions for the days immediately after the vaccine.
It’s a good idea to take into account the competition calendar and any training breaks. Vaccination after the start of the flu season can be helpful. The injected location can also be a temporarily sore, which should be taken into consideration by the athlete. It’s a good idea to choose the injection location based on your sport: for example, a tennis player shouldn't take it in their dominant hand.
Washing hands is the best way to protect yourself, i.e., adequate hand hygiene should be maintained at all times. Proper cough hygiene is also important for spreading the disease, i.e., you should always cough in your sleeve and not in your hand. If someone seems to have a cold, it’s a good idea to keep them 1–2 metres away.
In sports teams, it’s good to isolate people with influenza, because even if everyone has been vaccinated, the influenza vaccine does not provide full 100% protection. However, if people who have received the influenza vaccine become ill, the disease is often milder than it would have been without the vaccine.
Influenza can cause long periods of absence from training, competitions or matches. In addition, people with influenza also have a higher risk of sequelae than people with a normal flu.
The annual seasonal influenza vaccine is only available in Finland from around September-October until the spring of the following year. If the vaccine is no longer available in Finland and the trip is a longer one, it can be taken in the destination country if necessary, for example, if travelling to the southern hemisphere.
The vaccine protection develops within two weeks after vaccination. If you want to have the protection before being possibly exposed, it is advisable to take the influenza vaccine at least two weeks before the trip.
In addition, a high-dose influenza vaccine is available for people aged over 60. The high-dose vaccine contains a larger amount of active ingredient than the standard vaccine used in the national vaccination programme.
In addition to the injectable vaccines, a quadrivalent nasal spray influenza vaccine is available for children aged 2–17. The virus strains used in all the vaccines are in line with WHO recommendations.